For HRRm prostate cancer, will you use olaparib alone or in combination with abiraterone?
Answer from: Medical Oncologist at Academic Institution
The combination of a PARP inhibitor with a next-generation hormonal agent, including the combination of olaparib with abiraterone acetate, is not an FDA-approved combination and I do not recommend using it at this time. Both PROpel and MAGNITUDE showed a PFS benefit for the combination versus abirat...